Consistent with previous studies in pancreatic cancer [20], we observed a global decrease in the expression of miR-34a in pancreatic CSCs and cell lines independent of their p53 mutational status relative to non-neoplastic pancreatic epithelial cells (Fig. 1A). The gene discussed is TP53; the disease is familial pancreatic carcinoma.